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Abstract: Objective: to compare the amount of new bone produced by Bio-Oss
® Collagen to that produced by collagen 
matrix in vivo.  
Method: eighteen bone defects, 5mm by 10mm were created in the parietal bone of 9 New Zealand White rabbits. 6 
defects were grafted with Bio-Oss
® Collagen. 6 defects were grafted with collagen matrix alone (positive control) and 6 
were left empty (negative control). Animals were killed on day 14 and the defects were dissected and prepared for 
histological assessment. Quantitative analysis of new bone formation was made on 100 sections (50 sections for each 
group) using image analysis.  
Results: A total of 339% more new bone was present in defects grafted with Bio-Oss
® Collagen than those grafted with 
collagen matrix (positive control). No bone was formed in the negative control group.  
Conclusion: Bio-Oss
® Collagen has the effect of stimulating new bone formation locally compared with collagen matrix 
in vivo. Bio-Oss
® Collagen may be utilized as a bone graft material. 
Keywords: Bone graft, Collagen, Bio-Oss
® Collagen. 
INTRODUCTION 
  Discovery of bone substitute that enhance bone formation 
or to improve bone healing is needed for the treatment of 
bone trauma or surgery. The use of autogenous bone grafts 
requires a harvesting procedure at a donor site, which means 
increased morbidity [1,2]. In addition, graft resorption is a 
problem. Zin and Whitaker showed autogenous bone graft 
have 65% of bone loss after grafting [3]. One way to 
overcome this problem would be to use bone substitutes 
alone as a osteoconductive scaffold for bone regeneration 
from the residual bone [4] or in combination with 
autogenous bone, which also has osteoinductive properties 
[5]. Early studies with xenografts like the ‘Kiel bone’ or 
‘Oswestry bone’ half a century ago showed side effects like 
sterile fistulas and their use was discontinued [6-8]. Bio-
Oss
® (Geistlisch Pharmaceutical, Wolhusen, Switzerland) is 
deproteinized bovine cancellous bone developed in the last 
decade with a structure similar to human bone and with 
osteoconductive properties [9]. It is a natural, non-antigenic, 
porous bone mineral matrix. It is produced by removal of all 
organic components from bovine bone. Several animal 
studies have shown this material to be promising in 
comparison with other bone substitutes [9,10]. Bio-Oss
® 
Collagen is a combination of purified cancellous natural 
bone mineral granules (Bio-Oss
®) and 10% collagen fibres in 
a block form and is sterilized by -irradiation. The collagen 
facilitates handling of the graft particles and acts to hold the 
Bio-Oss
® Collagen at the desired place. The consistency of 
this material readily allows it to take the shape of the defect. 
Clinically it does not seem to have the immunological side 
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effects mentioned above [11,12]. It is of interest to know 
whether it enhances the healing of a bone defect by 
increasing the amount of new bone formation locally. 
Therefore, in the present study we examined the amount of 
new bone produced by Bio-Oss
® Collagen grafted into bony 
defects in rabbits and compared with those of collagen 
matrix graft (positive control) and no graft (negative 
control). Collagen matrix (purified absorbable fibrillar 
collagen) was used in this study because it had been used 
successfully as a carrier for growth factors like BMP-2 to 
induce bone formation in animals and in humans [13]. It was 
derived from bovine tendon, in the fibrillar form and was 
suggested from the Manufacturer (Collagen Matrix, Inc NJ, 
USA) to be useful for delivering cells and growth factors and 
for gene therapy and it was successfully used with rhBMP-2 
in the repair of alveolar clefts in humans [14].  
MATERIALS AND METHODS 
Preparation of Bio-Oss
® Collagen (Experimental Group) 
  0.2 mL of water of injection was mixed with 100mg of 
Bio-Oss
® Collagen to form a paste. The mixture was soaked 
for 15 minutes before grafting. 
Preparation of Collagen Matrix (Positive Control Group) 
  0.2 mL of water of injection was mixed with 20mg of 
collagen matrix (purified fibrillar collagen, Collagen Matrix, 
Inc NJ, USA) to form a paste. The mixture was soaked for 
15 minutes before grafting. 
Experimental and Control Groups 
  The protocol of Wong and Rabie [15] was followed. 
Eighteen 105mm full-thickness bone defects were created 
in the parietal bones of 9 New Zealand White rabbits from 
an inbred colony. The rabbits were 5 months old (adult 72    The Open Biomedical Engineering Journal, 2010, Volume 4  Wong and Rabie 
stage) and weighed 3.5-4.0 kg. The handling of the animals 
and the experimental protocol were approved by the 
Committee on the Use of Live Animals in Teaching and 
Research, the University of Hong Kong. In the experimental 
group, 6 defects were grafted with Bio-Oss
® Collagen. In the 
control groups, 6 defects were grafted with collagen matrix 
(positive control); 6 defects were left empty (negative 
control). The sample size was based on previous research 
using this model. For the experimental group and the control 
groups, two defects were created on the parietal bone of each 
rabbit. In each group six defects were created and surgery 
performed but after sacrifice only five was randomly drawn 
and prepared for analyses.  
Surgical Procedures 
  The animals were premedicated 1 hour before surgery 
with oxytetracycline hydrochloride (200mg/mL, 30mg/kg 
body weight, Tetroxyla, Bimeda, Dublin, Ireland) and 
buprenorphine hydrochloride (0.3mL/kg body weight, 
Hypnorm, Janssen Pharmaceutical, Beerse, Belgium), 
supplemented with diazepam (5mg/mL, 1mg/kg body 
weight, Valium 10, Roche). In order to maintain the level of 
neuroleptanalgesia, increments of Hypnorm (0.1mL/kg) 
were given at 30-min intervals during the operation. The 
surgical procedure consisted of the creation of one or two 
105mm full-thickness (approximately 2mm) cranial 
defects, devoid of periosteum, using templates, in the 
parietal bones (Fig. 1). The defects were produced using 
round stainless steel burs (1mm in diameter) on a low speed 
dental drill. Outlines of the defects were made initially by 
making holes of full thickness the parietal bone using a 
stainless steel wire template bent to the required size of the 
defect. The holes were joined to complete the process. 
During the cutting of bone, copious amount of sterile saline 
was used for irrigation and to minimize thermal damage to 
the tissues. Depending on which groups in which the rabbit 
belonged, the defects were grafted with different materials. 
In the experimental groups, the defects were filled with Bio-
Oss
® Collagen or collagen matrix as described above. In the 
negative control group, the defects were left alone.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). diagram of the dorsal view of the skull of a rabbit, showing 
the sites of two surgically-created bone defects. 
Postoperative Care 
  All wounds were closed with interrupted 3/0 black silk 
sutures. No attempt was made to approximate the periosteum 
to prevent the barrier effect. Postoperatively, the rabbits were 
given oxytetracycline hydrochloride daily for 10 days and 
buprenorphine hydrochloride for 2 weeks. Two weeks after 
surgery, the animals were killed with sodium pentobarbitone. 
Immediately upon death, defects and surrounding tissue were 
removed for histological preparation. 
Histological Preparation and Analysis 
  Tissues were fixed in 10% neutral buffered formal saline 
solution, demineralized with K’s Decal Fluid (sodium 
formate/ formic acid), and finally double embedded in 
celloidin/ paraffin wax. Each tissue sample containing the 
defect was embedded intact. Serial, 5-m-thick sections of 
the whole defect were cut perpendicular to the long axis. 
Quantitative analysis was made on serial sections of defects 
in the experimental and the active control groups. Defects 
were divided into 5 regions spaced 1500 m apart (Fig. 1). 
From the serial sections in each region, 2 sections were 
selected randomly, giving a total of 10 sections from each 
defect. Therefore, the amount of new bone formation was 
assessed throughout the whole defect. The total amount of 
new bone formed within the surgically-created defect was 
measured on 100 sections with a technique previously 
described Wong and Rabie [15,16]. Each section included 
the graft and host bone of both sides of the defect. Thus there 
were 2 graft-host interfaces. The total amount of new bone 
formed in both graft-host interfaces within the surgically 
created defect was quantified by one observer (blinded - who 
did not know which group he was measuring), by outlining 
the periphery of the newly formed bone image in the 
computer screen (Leica Qwin Image Processing & Analysis 
Software, V2.3, Leica Microsystems Imaging Solutions Ltd, 
UK) using a transmitted light microscope (Leica, DMLB, 
Germany) fitted with a video camera (Single CCD Color 
Camera, Tk-C1380E, JVC, Japan). Differences in staining 
properties and morphology between newly-formed bone and 
mature bone made identification easy (Fig. 2). The computer 
image analysis system then calculated the area of the 
outlined new bone. 
Statistical Methods 
  Data were analyzed using a statistical analysis software 
(Graphpad Instat, v.2.04a, 1993, San Diego, USA). The one-
way analysis of variance (ANOVA) method was used to 
compare sections drawn from the five regions in each defect. 
The arithmetic mean, standard deviation (SD) and 95 per 
cent confidence intervals were calculated for each 
experimental group. The means (Bio-Oss
® group and 
collagen matrix positive control group) were compared by 
the Welch’s unpaired t-test which does not assume equal 
variances, with p<0.05 chosen as the critical level of 
statistical significance.  
  The size of the method error in digitizing the areas of 
new bone was calculated by the formula ±
d
2 
2n
, where d 
was the difference between the two registrations of a pair 
and n was the number of double registrations. The size of the Bio-Oss
® and Bone  The Open Biomedical Engineering Journal, 2010, Volume 4    73 
method error is 0.014mm
2. Ten randomly drawn histological 
sections were digitized on two separate occasions at least 
three months apart by the same observer and also by an 
independent observer. Paired t-tests were also performed to 
compare the intra-observer and the inter-observer 
registrations. The two-tailed p value to compare the intra-
observer registrations was 0.5652, that to compare the inter-
observer registrations was 0.5911, both considered not 
significant. 
RESULTS 
Clinical and Physical Examinations 
  All animals remained in excellent health throughout the 
course of the experiment and recovered rapidly after 
operation. There was no evidence of side effects or infection 
in any of the animals. 
Histological Findings: Experimental Group 
  In the group grafted with Bio-Oss
® Collagen, new bone 
was formed at the host bone-graft interface and tended to 
grow across the defect (Fig. 2). Integration of the Bio-Oss
® 
Collagen with the recipient bed was characterized by the 
presence of new bone. No cartilage was found. At higher 
magnification (Fig. 3), new bone could be seen growing 
towards and amalgamating with the Bio-Oss
® granules, bone 
cells were present showing that the collagen was not just 
calcified, rather, new bone was formed. In the collagen 
matrix positive control group little new bone was formed at 
the host bone – graft interface. Some collagen fibers were 
present at the centre of the defects (Fig. 4). In the negative 
control group, the defect was healed, with fibrous tissue 
bridging across the defect. Very little new bone had formed 
at the ends of the host bone, therefore no quantitative 
analysis was performed.  
Quantitative Analysis 
  A total of 100 sections of the experimental group and 
positive control group were digitized and analyzed. The 
amount of newly formed bone was significantly greater in 
the defects grafted with Bio-Oss
® Collagen than in those 
grafted with collagen matrix (positive control) (Tables 1-3). 
In the Bio-Oss
® Collagen group, 50 sections were measured; 
the mean area of newly formed bone in each defect was 
1.80mm
2, with a standard deviation of 0.75mm
2. In the 
positive control group, 50 sections were measured; the mean 
area of newly formed bone in each defect was 0.41mm
2, with 
a standard deviation of 0.27mm
2. Welch’s unpaired t  test 
which does not assume equal variances was used to test the 
difference between the two groups, the two-tailed p value is 
<0.0001, considered significant.  
DISCUSSION 
 In  vivo Bio-Oss
® Collagen has significantly more new 
bone formation locally compared with collagen matrix 
(positive control) when grafted into skull defects. It 
produced 339% more new bone than the collagen matrix, 
(Table  3). The difference was significant (p<0.0001, 
unpaired t test). This showed that Bio-Oss
® Collagen was 
more osteogenic when compared with collagen matrix.  
  The rabbit model used in this study was relevant because 
non-grafted negative control bone defects have been found 
not to heal with new bone formation within fourteen days 
after their creation. In addition, there was minimal bone 
healing across the defect as shown by the results of the 
negative control group. There was minimal morbidity due to 
this procedure as all the rabbits were in good health and 
condition after the surgery. Two weeks was chosen to 
examine the bone formation during the early healing of the 
bone defect was based on another study [16]. It gave better 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). photomicrograph showing healing of a bony defect grafted with Bio-Oss
® Collagen on day 14. New bone (N) can be seen near the 
margins of the defect. H = host bone. Some Bio-Oss
® granules (B) remained at the centre of the bony defect (periodic acid-Schiff stain, 
original magnification 40). Image inside box was enlarged in Fig. (3). 74    The Open Biomedical Engineering Journal, 2010, Volume 4  Wong and Rabie 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). high power photomicrograph showing the formation of new bone in a bony defect grafted with Bio-Oss
® Collagen (box in Fig. 2). 
New bone (N) with osteocytes (O) could be seen growing around the Bio-Oss
® granules (B) from the margin of the host bone defect (H). 
Capillaries (cap) were present. No cartilage was found. (periodic acid-Schiff stain, original magnification 200).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4). photomicrograph of defect grafted with collagen matrix in day 14. No bone could be seen across the defect except for a little new 
bone (N) near the ends of the host bone (H). Collagen matrix (C) remained across the bone defect (periodic acid-Schiff stain, original 
magnification 40).  Bio-Oss
® and Bone  The Open Biomedical Engineering Journal, 2010, Volume 4    75 
Table  1.  Comparison of Amounts of New Bone (mm
2) in Five Defects Grafted with Bio-Oss
® Collagen. Mean and Standard 
Deviation (SD) of the 10 Sections of Each Defects, and Results of ANOVA (Degree of Freedom [df], F, P) Comparing Five 
Regions within Each Defect 
Region  Defect 1  Defect 2  Defect 3  Defect 4  Defect 5 
2.72 1.22 1.56 2.13 3.47  A 
2.70 1.24 1.50 2.25 3.18 
1.96 1.23 1.52 1.91 3.86  B 
1.97 1.06 1.37 1.05 3.28 
1.47 0.87 1.77 1.23 1.99  C 
1.54 0.89 2.23 0.96 1.72 
1.29 1.30 1.75 1.40 2.80  D 
1.80 0.89 1.65 1.11 3.02 
1.66 1.52 1.12 1.59 2.71  E 
1.67 1.01 1.43 1.47 3.13 
Mean 1.878 1.123  1.59  1.51  2.916 
SD  0.4857 0.2142 0.2944 0.4552 0.6498 
df  4,5 4,5 4,5 4,5 4,5 
F  18.735  1.004 4.422 3.787  11.980 
P  0.0033 0.4841 0.0672 0.0883 0.0090 
 
Table 2.  Comparison of Amounts of New Bone (mm
2) in Five Defects Grafted with Collagen Matrix Positive Control. Mean and 
Standard Deviation (SD) of the 10 Sections of Each Defects, and Results of ANOVA (Degree of Freedom [df], F, P) 
Comparing Five Regions within Each Defect 
Region  Defect 1  Defect 2  Defect 3  Defect 4  Defect 5 
0.68 0.64 0.18 0.12 0.41  A 
0.74 0.82 0.18 0.11 0.42 
0.57 0.68 0.15 0.31 0.29  B 
0.51 0.71 0.16 0.38 0.34 
0.70 0.85 0.35 0.23 0.31  C 
0.70 0.96 0.32 0.18 0.35 
0.58 0.86 0.20 0.22 0.07  D 
0.74 0.95 0.21 0.24 0.08 
0.60 0.51 0.06 0.15 0.11  E 
0.80 0.62 0.06 0.13 0.09 
Mean  0.662 0.76 0.187  0.145  0.247 
SD  0.09223 0.1503 0.09393  0.07412 0.1431 
df  4,5 4,5 4,5 4,5 4,5 
F  1.379  6.494  179.23 34.071 96.734 
P  0.3603  0.0324 <0.0001 0.0008 <0.0001 
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Table  3.  Comparison of Mean (SD) Area of Newly Formed 
Bone (mm
2) Between Defects Grafted with Bio-Oss
® 
Collagen and that of Defects Grafted with Collagen 
Matrix (mm
2) 
Group Mean  (SD)  P value 
Bio-Oss
®  1.80 (0.75)   < 0.0001 
Positive Control  0.41 (0.27)   
 
indication of the ability of new bone to grow across the bone 
defect. It was also the time span chosen for other studies on 
bone formation using the same animal model [15-22] so that 
comparisons can be performed. 
  The results of the ANOVA of the different regions within 
each defect showed the necessity to analyze multiple regions 
within each defect (Tables 1, 2). This was indicated by the p 
value, the difference in the amount of new bone formed 
between the different regions within each defect was 
statistically significant in many defects. There was 
variability because the two sections in each region to be 
measured were randomly selected among the serial sections. 
Despite the variations in the amount of bone formation in 
different regions and in different defects, the amount of bone 
formation of the Bio-Oss
® group was greater than that in the 
collagen matrix positive control group. 
  This is the first study that demonstrated Bio-Oss
® 
Collagen has significant local osteogenic effect. It is possible 
that the surfaces of the Bio-Oss
® granules facilitate 
mineralization as new bone was forming around the granules 
(Fig. 3). This may provide a surface for mineralization or 
provide a source of calcium ions which facilitate 
mineralization. Further research is needed to gain further 
understanding on its bone forming mechanism and to 
optimize its use and to demonstrate that Bio-Oss
® granules 
are lack on antigenicity and do not show long term side 
effects. 
 To  conclude,  Bio-Oss
® Collagen has effect of increasing 
new bone formation locally and this may be utilized for bone 
grafting.  
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